Botanical species · safety record

Lupinus angustifolius

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Lupinus angustifolius. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lupinus angustifolius L.

6Constituent measurements

1Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Seed	Solvent extraction	1107 Milligram/kilogram	GC-MS	Resolve DOI
Angustifoline	Seed	Solvent extraction	257 Milligram/kilogram	GC-MS	Resolve DOI
Lupanine	Seed	Solvent extraction	552 Milligram/kilogram	GC-MS	Resolve DOI
Alkaloids	Fruit unspecified	Solvent extraction	1.46 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Alkaloids	Leaves	Solvent extraction	0.64 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Alkaloids	Seed	Solvent extraction	1.47 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Musclo-skeletal	Muscle, skeletal	Seed	—	Gallus gallus (chicken) (as animal)	Short-term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Resta, Donatella., Boschin, Giovanna., D'Agostina, Alessandra., Arnoldi, Anna. Evaluation of total quinolizidine alkaloids content in lupin flours, lupin-based ingredients, and foods. MOLECULAR NUTRITION & FOOD RESEARCH, 2008, vol. 52, no. 4, p. 490-495. DOI
Gordon, W. Carl., Henderson, James H. M. The alkaloidal content of blue lupine (Lupinus angustifolius) and its toxicity on small laboratory animals. Journal of the Agricultural Society of the University College of Wales, 1951, p. 141-145.
Olkowski, AA., Olkowski, BI., Amarowicz, R., Classen, HL. Adverse effects of dietary lupine in broiler chickens. Poultry science, 2001, vol. 80, no. 5, p. 621-625.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature